AI assistant
Sending…
RenovoRx, Inc. — Director's Dealing 2025
Dec 22, 2025
34656_dirs_2025-12-22_32705bdf-7656-44fe-ae01-8fa6f066ee66.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RenovoRx, Inc. (RNXT)
CIK: 0001574094
Period of Report: 2025-12-18
Reporting Person: Bagai Shaun (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-18 | Common Stock | P | 5000 | $0.9013 | Acquired | 340040 | Direct |
Footnotes
F1: Reflects open market purchases of the Issuer's securities.
More from RenovoRx, Inc.
Annual Report
2026
May 15
Earnings Release
2026
May 14
Proxy Solicitation & Information Statement
2026
Apr 30
Capital/Financing Update
2026
Apr 27
Regulatory Filings
2026
Apr 16
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Board/Management Information
2026
Mar 27
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 25